Table 5 |
||||||
| Number of studies, patients and their distributions included in each analysis, for the immunocytochemistry technique | ||||||
| ICC ANALYSIS | STUDIES | PATIENTS | TP | FP | FN | TN |
| CK-19 [31,62,63] | 3 | 230 | 111 (48.3%) | 19 (8.3%) | 27 (11.7%) | 73 (31.7%) |
| GAL-3 [31,64-75] | 14 | 1785 | 581 (33.9%) | 103 (6.0%) | 104 (6.0%) | 927 (54.1%) |
| HBME-1 [31,62,64,66,74,76,77] | 7 | 3900 | 1501 (38.5%) | 324 (8.3%) | 436 (11.2%) | 1639 (42.0%) |
LEGEND: TP (true-positive), FP (false-positive), FN (false-negative) and TN (true-negative).
de Matos et al. Diagnostic Pathology 2012 7:97 doi:10.1186/1746-1596-7-97
